News

The research which was conducted by Jun Yan of University of Louisville School of Medicine in Louisville, Kentucky supports another study that found that differences in yeast-derived beta-glucan

MPV offers a suite of patient and payer management solutions that help physician practices and hospitals improve collections, minimize denied claims and accelerate reimbursement. MPV through a combination

Edge BioSystems will initially focus on sample preparation for exome, whole genome and RNA sequencing applications. Caliper has developed a suite of next generation sequencing tools, including the

Replagal is an enzyme replacement therapy for the treatment of Fabry disease. With this approval, the company now has two approved facilities, Alewife, and the new Lexington facility,

The company has already received orphan drug designation from the European Medicines Agency for Graspa as a treatment for pancreatic cancer. Erytech Pharma co-founder, vice president and chief

Prior to that Hinchen was the president and chief operating officer of JHP since the formation of the company in 2007. Hinchen said JHP has a wonderful opportunity

Adcetris MAA was filed as a treatment for relapsed or refractory Hodgkin lymphoma (HL) and relapsed or refractory systemic anaplastic large cell lymphoma (sALCL) by Takeda Global Research

Intivia as an EHR Vendor, will offer small practices drive EMR adoption and leverage the benefits of InSync EMR & Practice Management software. NJ-HITEC executive director Bill Byrne

Further, both the companies have also decided to expand the term of their drug discovery and research agreement to April 2012. The companies aim to generate new chemical